metadata: {"signature": "0xfbaa49f8c595de4c31311b3bfa7f726b34cf91f61f672f4d0cbeece8ad801afa605da625f4279ef3bb4e403aaef058ceac6860fa8eb2f448a3fe191d661e8a5a1c", "application": {"round": "0x347ff9951d24e29b559e3323b5370aa29993e613", "answers": [{"type": "email", "hidden": true, "question": "Email Address", "questionId": 0, "encryptedAnswer": {"ciphertext": "yPhL37GicjDqL4O42BoE469yNJKGfatKKEmetJG6wzVwZUZNhqXP+9qjdt7LYs+Q", "encryptedSymmetricKey": "bd47b80f52da18e11756b310bcecb9d82294d75f9bc336a3c20f3d02230469019ab10d3e39b8d70aa120e460ae464e110513cc69f175b7bd8e3742c724389b7fcb77fb05f666ee6f2a52fa3d6401530d3190764d18609267bf1236d6631484b90d814e4abf02ca9a52ff4bca7688d6d0edb3d41f8c531f3d0ed1fe36421e86d4000000000000002022398008a55f82712b095ccb9c9fec5c52b207e03442d72e55a12037d289a342a5f19efecdde58df9cf14495cc7e93a2"}}, {"type": "short-answer", "answer": "team funded", "hidden": false, "question": "Funding Sources (how is the project financed outside of this round)", "questionId": 1}, {"type": "number", "answer": "5", "hidden": false, "question": "Team Size (including full and part time)", "questionId": 2}, {"type": "paragraph", "answer": "We are building collaborating computing for scientists. You can think of the platform as like a web3 google colab. Here is a demo video of our MVP that is already in use by scientists at UCLA and Stanford. https://drive.google.com/file/d/1lfr1MeY1NX5o6mFF7zuMNsNCAnzXDdFh/view?usp=sharing", "hidden": false, "question": "How is the project CollabTech?", "questionId": 3}, {"type": "paragraph", "answer": "The target user group is rare disease researchers. A series of problems plague this space:\n\nThere are over 7,000 different types of rare diseases, affecting an estimated 25-30 million people in the United States alone.[1][5]\n95% of rare diseases lack an FDA-approved treatment.[1] This is largely due to the high costs and difficulties in conducting clinical trials with limited patient pools.\nOn average, it takes 4.8 years for a rare disease patient to receive an accurate diagnosis.[1] The diagnostic odyssey is long and arduous, delaying potential treatment.\nOnly 1 in 2 rare diseases have a foundation or research support group behind them, leaving many without advocacy or funding for research.[1]\n3 out of 10 children with a rare disease will not live to see their 5th birthday.[1] Many rare diseases are serious, life-threatening conditions lacking effective therapies.\nStudying rare diseases is challenging due to small data and sample sizes. For instance, one study on alkaptonuria, a rare metabolic disorder, had a cohort of just 125 patients - the largest of its kind.[3]\nPharmaceutical companies have historically lacked incentives to invest in developing treatments for rare diseases with small market potential. The Orphan Drug Act of 1983 aimed to address this by providing financial incentives.[3]\n", "hidden": false, "question": "Who's the targeted user group and what's the need/problem being addressed?", "questionId": 4}, {"type": "paragraph", "answer": "Rare Compute's business model is designed to generate sustainable revenue through multiple channels while accelerating rare disease research. Our core offering is an innovative web application that empowers scientists with cutting-edge computational tools and data science solutions.\nWe provide on-demand GPU access using a pay-as-you-go model, enabling researchers to deploy code via Jupyter Notebooks, VS Code, or RStudio servers at a significantly lower cost compared to traditional cloud hosting. Access to the platform requires a one-time membership fee and a unique access token. To further diversify revenue, we lease idle hardware on our partners' compute networks. This multifaceted approach includes one-time fees, recurring subscriptions, and services revenue.\n", "hidden": true, "question": "How do you ensure value keeps being delivered after the round is over? (How will the project become commercially sustainable or a perennial good? )", "questionId": 5}, {"type": "paragraph", "answer": "Funding will be used to help build our second server node! As such funds will be used for development and hardware costs. To get the server node operational will take approximately 6 weeks. ", "hidden": true, "question": "How long will it take after funding is received to deliver value? (share a high level timeline)", "questionId": 6}, {"type": "paragraph", "answer": "@reneedaos on telegram", "hidden": true, "question": "Contact info (telegram handle or whatsapp)", "questionId": 7}], "project": {"id": "0xd396b745d5067050d08838d2a456310bc0bec11543fd5ffda0bd105ea26b169f", "title": "Rare Compute", "logoImg": "bafkreibbrchwyo264ls4n4dgh2lrnow7mxk2paydiief56bassjm63mzwm", "metaPtr": {"pointer": "bafkreid2tshstrwmzbkoz76dovi6nidzppg4zltsrxecz64ct4zvtyb6p4", "protocol": "undefined"}, "website": "https://rarecompute.io", "bannerImg": "bafkreicbqorn6ipxuvbrxmevjrntwu6fnsoxilalhaba5cnz7krtfov2ai", "createdAt": 1722355977956, "credentials": {"twitter": {"type": ["VerifiableCredential"], "proof": {"jws": "eyJhbGciOiJFZERTQSIsImNyaXQiOlsiYjY0Il0sImI2NCI6ZmFsc2V9..53D6DztJN1o7NJ3kAmJzUHpkNeZrt9Dk349QakOJSWLQAbpiKvfwBRPerP96VFhZ7fo8l1EBCl1t8_PoFswnBg", "type": "Ed25519Signature2018", "created": "2024-07-30T16:12:37.882Z", "proofPurpose": "assertionMethod", "verificationMethod": "did:key:z6MkghvGHLobLEdj1bgRLhS4LPGJAvbMA1tn2zcRyqmYU5LC#z6MkghvGHLobLEdj1bgRLhS4LPGJAvbMA1tn2zcRyqmYU5LC"}, "issuer": "did:key:z6MkghvGHLobLEdj1bgRLhS4LPGJAvbMA1tn2zcRyqmYU5LC", "@context": ["https://www.w3.org/2018/credentials/v1"], "issuanceDate": "2024-07-30T16:12:37.882Z", "expirationDate": "2024-10-28T16:12:37.882Z", "credentialSubject": {"id": "did:pkh:eip155:1:0xc552bE1Ec0ad57c01303C21B7E2D6BdfD428Ab65", "hash": "v0.0.0:WGas4ECaEYksrkPDULFHIM7n3Oz3CkbxyYc6uYgLz9Q=", "@context": [{"hash": "https://schema.org/Text", "provider": "https://schema.org/Text"}], "provider": "ClearTextTwitter#rarecompute"}}}, "description": "A new era in genetic understanding has arrived, and Rare Compute stands at the forefront, harnessing the power of GPU-driven technology to unravel the mysteries of rare genetic diseases. Our mission is to deliver relief and answers to the millions affected worldwide, ensuring no patient is left behind. By prioritizing the fight against rare diseases, we aim to improve countless lives and fuel groundbreaking discoveries that will reshape our understanding of human biology.\n\nRare Compute is a democratic, non-profit consortium uniting patients, doctors, and scientists under a singular focus: conquering debilitating rare diseases. Our passionate team selects the most promising research projects, providing them with the essential computational resources needed to accelerate progress toward life-changing treatments and cures.\n\nJoin us in this critical mission as we mobilize the power of GPU-driven technology to unravel the complexities of DNA. Together, we can empower a global community eager for breakthroughs, placing hope back into the hands of those who suffer from rare diseases and giving long-awaited answers to the families who need them most, We're here to make a difference and change lives, one discovery at a time.", "lastUpdated": 0, "projectTwitter": "rarecompute"}, "recipient": "0x1444bbDa110A01c5fa2E431da51366F456116232"}}